Bioinformatics & Multi-Omics
Sequence faster than you can interpret? That is the problem we solve.
USD 60–240K per year · 8–16 weeks to deploy · Validated pipeline, structured reports, turnaround SLA
At a glance
- Price band
- USD 60–240K per year
- Deployment
- 8–16 weeks
- Deliverable
- Validated pipeline + reports
- Commitment
- Turnaround SLA
Indicative list price. Final scope and price confirmed in the proposal.
Talk to a scientistThe problem
Why teams buy this
Hospital and reference laboratories can generate sequence data far faster than they can interpret it. Interpretation quality varies between analysts, turnaround stretches, and clinicians wait for reports that should take days.
What you get
Deliverables, not activity
- A validated analysis pipeline, benchmarked against reference material
- Automated annotation with aggregated evidence
- A guideline-aligned classification workflow with reviewable, structured reports
- A turnaround-time service level
- Training for your staff, and continuous pipeline and knowledge-base updates
Who this is for
Hospital laboratories · reference laboratory networks · precision-medicine programmes · national genomics initiatives.
Proof
Representative result
A validated hereditary-cancer interpretation workflow that cut a hospital laboratory's reporting turnaround from 21 days to 6.
Representative programme - illustrates typical scope and outcomes; not an individual client account. Client-specific references are available on request under confidentiality.
Next
What we would suggest next
Questions we get asked
The awkward ones, answered
Can the data stay in our country?
Yes. In-region deployment is available and is designed in from the first proposal, not retro-fitted.
Do you replace our analysts?
No. We increase their throughput and consistency, and we train them.
Enterprise AI for Life Sciences
Ready to Advance Your Drug Discovery Pipeline?
Partner with Prognica Labs to leverage enterprise-grade AI, computational chemistry, and molecular simulation technologies that accelerate discovery, reduce development risk, and improve R&D productivity.
From biotech startups to global pharmaceutical organizations, we help research teams make faster, evidence-driven decisions across every stage of early drug discovery.